Program (As of December 15, 2017 )
Àλ縻 | ¡¡08:50-09:00 | |
1. Integration of molecular tumor board into the clinic | ¡¡09:00-10:30 | |
ÁÂÀå: ±è°æ¹Ì (¼º±Õ°üÀÇ´ë) | ||
1) ´ÙÀ½ ¼¼´ë¸¦ À̲ø¾î °¥ ÀþÀº »ý¸í°úÇÐÀÚ ¹× ÀÇ°úÇÐÀÚ°¡ ÇØ¾ß ÇÒ ¾Ï ¿¬±¸´Â ¹«¾ùÀΰ¡? | ¹é¼ø¸í (¿¬¼¼ÀÇ´ë) | |
2) Genome-guided high-throughput sequencing for a matched therapy | ±è½ÂÅ (¼º±Õ°üÀÇ´ë) | |
3) Practical considerations in development of clinical cancer genomic profiling test | À±È«¼® (¼¿ï´ëº´¿ø Á¤¹ÐÀÇ·á¼¾ÅÍ) | |
Coffee Break | ¡¡10:30-10:50 | |
2. ¾Ï ¿¬±¸ÀÚ¸¦ À§ÇÑ R&D °úÁ¦ ¼öÁÖ ¹× ¼öÇà Àü·« | ¡¡10:50-12:20 | |
ÁÂÀå: ±è¿È« (°í·ÁÀÇ´ë) | ||
1) Çѱ¹¿¬±¸Àç´Ü ÀǾàÇдÜÀÇ R&D ÃßÁø¹æÇâ | ¹ÚÇåÁÖ (Çѱ¹¿¬±¸Àç´Ü ÀǾàÇдÜÀå) | |
2) ±¹°¡ R&D ¹æÇâ ¹× ¿¬±¸°úÁ¦ ºÐ¼® ³ëÇÏ¿ì | À±°æ½Ä (Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø) | |
3) âÀÇÀûÀÎ Á¦¾È¼ ÀÛ¼º ¹× ¹ßÇ¥Æò°¡ ´ëÀÀÀü·« | ¹ÚÁöÇö (»ïÀÏȸ°è¹ýÀÎ PwC) | |
4) °æÀï·Â ÀÖ´Â R&D ¼öÇàÀÇ ³ëÇÏ¿ì | ¼¿µÁØ (¼¿ï´ë ¾àÇдëÇÐ) | |
Q&A, Discussion | ||
Lunch | ¡¡12:20-13:20 | |
3. Novel methodology for cancer research | ¡¡13:20-14:50 | |
ÁÂÀå: ÀÌ´ëÈ£ (¿ï»êÀÇ´ë) | ||
1) Methods for immuno-biology research | ½ÅÀÇö (KAIST) | |
2) 3-Dimensional view of BRCA2 in the mouse and human pancreas organoids and the future in precision medicine |
ÀÌÇö¼÷ (¼¿ï´ë ÀÚ¿¬°úÇдëÇÐ) | |
3) Methods for bioimaging research | ±è»ó¿± (¼¿ï¾Æ»êº´¿ø ÀÇ»ý¸í¿¬±¸¼Ò) | |
Coffee Break | ¡¡14:50-15:10 | |
4. Single cell genomics | ¡¡15:10-16:40 | |
ÁÂÀå: ±èŹΠ(¼¿ïÀÇ´ë) | ||
1) Novel single-cell profiling technology for immune cells | ÀÌÀ¯Á¤ (POSTECH) | |
2) Novel single-cell profiling technology for cancer cells | ÀÌÇý¿Á (»ï¼º¼¿ïº´¿ø À¯Àüü¿¬±¸¼Ò) | |
3) Intratumoral heterogeneity and phylogenetic analyses of cancer genomes | ±èŹΠ(°¡Å縯ÀÇ´ë) |